CLINICAL_TRIALS
trial_result
· 2025-11-24
Clinical Trial Update: A Study in Recurrent Glioblastoma (GB) [Phase 2]
Summary
Phase 2 results from a Lilly-sponsored study in recurrent glioblastoma have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Eli Lilly and Company | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2025-11-24